Literature DB >> 11208004

Endomysium antibodies in the diagnosis of celiac disease in short-statured children with no gastrointestinal symptoms.

L Tümer1, A Hasanoglu, C Aybay.   

Abstract

BACKGROUND: Endomysium antibodies (EmAb) are strongly associated with untreated celiac disease and are suggested to be diagnostic. The aim of the present study was to assess the value of anti-EmAb for celiac disease screening in children with short stature.
METHODS: In 84 children with height less than the third percentile for age, preliminary work-ups were made to find a cause for their short stature and then their serum was assayed for anti-EmAb by indirect immunofluorescence tests using monkey esophagus.
RESULTS: Seven children were strongly positive for EmAb and all had positive histologic findings for celiac disease.
CONCLUSIONS: Our results show that there is an association with occult celiac disease and idiopathic short stature and that the serum anti-EmAb test is useful in identifying such cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11208004     DOI: 10.1046/j.1442-200x.2001.01327.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  10 in total

1.  Management of celiac disease in childhood and adolescence: unique challenges and strategies.

Authors:  Ivor D Hill
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

2.  Screening children with severe short stature for celiac disease using tissue transglutaminase.

Authors:  Faraz Ahmad; Seema Alam; Indu Shukla; Rana Sherwani; Syed M Ali
Journal:  Indian J Pediatr       Date:  2010-03-19       Impact factor: 1.967

3.  The prevalence of growth hormone deficiency and celiac disease in short children.

Authors:  Diletta Giovenale; Cristina Meazza; Giuliana M Cardinale; Maddalena Sposito; Costanzo Mastrangelo; Beatrice Messini; Giuseppe Citro; Maurizio Delvecchio; Salvatore Di Maio; Mauro Bozzola
Journal:  Clin Med Res       Date:  2006-09

4.  Short Stature and Celiac Disease in Children (5 to 16 Years) Presenting at a Tertiary Care Hospital in Peshawar.

Authors:  Amir Muhammad; Nauman Arif; Khawaja Kamran Wajid; Khalid Rehman; Naila Sardar; Palwasha Khan; Umar Hussain
Journal:  Cureus       Date:  2022-06-19

5.  LCN2 is a new diagnostic biomarker and potential therapeutic target in idiopathic short stature.

Authors:  Xijuan Liu; Jian Zhang; Jinghong Yuan; Rui Ding; Tao Liu; Jingyu Jia
Journal:  J Cell Mol Med       Date:  2022-05-24       Impact factor: 5.295

6.  Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-07-01

7.  Prevalence of celiac disease in Iranian children with idiopathic short stature.

Authors:  Jalal Hashemi; Eskandar Hajiani; H-Bb Shahbazin; Rahim Masjedizadeh; Navab Ghasemi
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

8.  The pre-treatment characteristics and evaluation of the effects of recombinant human growth hormone therapy in children with growth hormone deficiency and celiac disease or inflammatory bowel disease.

Authors:  Ewelina Witkowska-Sędek; Dominika Labochka; Anna Majcher; Beata Pyrżak
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

9.  Evaluation of malnutrition status and clinical indications in children with celiac disease: a cross-sectional study.

Authors:  Zahra Setavand; Maryam Ekramzadeh; Naser Honar
Journal:  BMC Pediatr       Date:  2021-03-29       Impact factor: 2.125

Review 10.  A glimpse into the black box of celiac disease complications: a case report with a rare presentation.

Authors:  Natalya Viktorovna Rylova; Ahmed Arafat; Almazia Raisovna Shakirova; Ilyuza Shaidullina; Rozaliya Zakirova
Journal:  Prz Gastroenterol       Date:  2021-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.